Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research CollaborationRelease Date:Call for Collaborator(s) Vaccines France, Germany Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Title Grant Type Focus Area Country Application Due Date Real World Experience with Biosimilar Medicines in OncologyRelease Date:Education Oncology All Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)Release Date:Quality Improvement Hospital All Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan COVID-19 Patient Awareness (United States and Europe)Release Date:Education Hospital All Improving Cytogenetic Testing & Treatment Guidance in Adult AMLRelease Date:Quality Improvement Oncology Canada Acromegaly Research- United StatesRelease Date:Research Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic MelanomaRelease Date:Education Oncology USA Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMARelease Date:Quality Improvement Inflammation & Immunology Italy ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy ChallengeResearch Oncology USA Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Research Hospital All